Amgen Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending March 31, 2025: USD -1.28 B

Amgen Inc. Net Cash Used For Investing Activities is USD -1.28 B for the Trailing 12 Months (TTM) ending March 31, 2025, a -95.41% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Amgen Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -27.78 B, a 507.19% change year over year.
  • Amgen Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -4.58 B, a -586.18% change year over year.
  • Amgen Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 941.00 M, a -117.14% change year over year.
  • Amgen Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -5.49 B, a -385.34% change year over year.
Key Data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Depreciation And Amortization Dividends Paid